Hematological disorders in HIV-infected children on the background of antiretroviral therapy
https://doi.org/10.22328/2077-9828-2021-13-3-73-80
Abstract
Introduction. In most cases, HIV infection in children is accompanied by the development of anemia.
Objective: to study the nature of the disturbance of the cellular composition of blood in HIV-infected children on the background of antiretroviral therapy.
Materials and methods. In the period from September 2015 to January 2017, 124 patients aged from 0 to 18 years old were examined with a diagnosis of HIV infection at various stages of its development. In all patients in the peripheral blood, the hemoglobin concentration, the absolute number of red blood cells, leukocytes and their varieties in a blood volume unit were determined, the hematocrit value was calculated.
Results and discussion. Against the background of ongoing antiretroviral therapy, the formation of hypochromic anemia is associated with a consistent decrease in hemoglobin concentration and the number of circulating red blood cells to 104,86±2,80 g/l and to 3,81–3,67×1012/l, which may be accompanied by a decrease in their content in each erythrocyte and the appearance of macrocytic erythroid forms in circulating blood. Leukopenia develops due to the formation of an absolute deficiency of circulating lymphocytes and neutrophilic granulocytes.
Conclusion. The specific assessment of cytopenia depends on the type of primary damage to the blood cells, and the choice of specific treatment depends on the type of disorder. Therefore, timely correction of these disorders could possibly reduce the development of the immunodeficiency state.
About the Authors
T. A. Daminov
Tashkent Medical Academy
Uzbekistan
Uzbekistan
Tashkent
L. N. Tuychiev
Tashkent Medical Academy
Uzbekistan
Uzbekistan
Tashkent
G. K. Khudaykulova
Tashkent Medical Academy
Uzbekistan
Uzbekistan
Tashkent
Sh. B. Rakhmatullaeva
Tashkent Medical Academy
Uzbekistan
Uzbekistan
Rakhmatullaeva Shakhnoza Bahadirovna
Tashkent
M. T. Muminva
Tashkent Medical Academy
Uzbekistan
Uzbekistan
Tashkent
References
1. Хасанова Г.Р., Степанова Е.Ю., Анохин В.А., Абросимова A.A. Анемия и ВИЧ-инфекция // Инфекционные болезни. 2009. Т. 7, № 3. С. 58–61. [Khasanova G.R., Stepanova E.Yu., Anokhin V.A., Abrosimova A.A. Anemia and HIV infection. Infectious diseases, 2009, Vol. 7, No. 3, рр. 58–61 (In Russ.)].
2. Канестри В.Г. Гематологические нарушения у больных с ВИЧ-инфекцией, получающих антиретровирусную терапию // ВИЧ-инфекция и иммуносупрессии. 2013. Т.5, №3. C. 63–70. [Kanestri V.G. Hematological disorders in patients with HIV infection receiving antiretroviral therapy. HIV Infection and Immunosuppressive Disorders, 2013, Vol. 5, No. 3, рр. 63–70 (In Russ.)].
3. Petrache, A., Moller M.B., Frederiksen H. Hemophagocytosis associated with cytomegalovirus infection and azathioprin treatment for inflammatory bowel disease // Ugeskr. Laeger. 2010. Bd. 172, No. 1. P. 52–53.
4. Бартлет Дж. Клинические аспекты ВИЧ-инфекции: пер. с англ. М., 2012. С. 474 [Bartlett J. Clinical aspects of HIV. Moscow, 2012, 474 р. (In Russ.)].
5. Старец Е.А., Котова Н.В. Анемия в раннем возрасте у детей с перинатальным контактом с ВИЧ // Клиническая педиатрия. 2008. № 5. С. 14. [Elder E.A., Kotova N.V. Anemia at an early age in children with perinatal contact with HIV. Clinical Pediatrics, 2008, No. 5, рр. 14 (In Russ.)].
6. Абросимова A.A., Хасанова Г.Р., Макарова М.В. Анемии у ВИЧ-инфицированных детей // Актуальные вопросы инфекционной патологии. Казань, 2007. 39 с. [Abrosimova A.A., Khasanova G.R., Makarova M.V. Anemia in HIV-infected children. Actual problems of infectious pathology. Kazan, 2007. 39 р. (In Russ.)].
7. Calis J.C.J., van Hensbroek, M.B., de Haan R.J., Moons P., Brabin B.J., Bates I. HIV-associated anemia in children: a systematic review from a global perspective // AIDS. 2008. Vol. 22. Р. 1099–1112.
8. Snopkova S., Matyskova M., Husa P., Svoboda R. Haemopoiesis defects in HIV/AIDS-anaemia // Klin. Mikrobiol. Infekс. Lek. 2005. Vol. 11, No. 4. P. 123–127.
9. Baillou C., Simon A., Leclercq V., Azar N., Rosenzwajg M., Herson S., Klatzmann D., Lemoine F.M. Highly active antiretroviral therapy corrects hematopoiesis in HIV-1 infected patients: interest for peripheral blood stem cell-based gene therapy // AIDS. 2003. Vol. 17, No. 4. P. 563–574.
10. Clarke S.M., Mulcahy F., Healy C.M. et al. The efficacy and tolerability of combination antiretroviral therapy in pregnancy: infant and maternal outcome // Int. J. STD. AIDS. 2000. Vol. 11, No. 4. P. 220–223.
11. Lorenzi P., Spicher V.M., Laubereau B. Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study // AIDS. 2008. Vol. 12, No. 18. P. F241–F247.
12. Шифман Е.М., Ройтман Е.В., Кругова Л.В., Вартанов В.Я., Хуторская Н.Н. Гематологические изменения у ВИЧ-инфицированных беременных на фоне химиопрофилактики антиретровирусными препаратами // Акушерство и гинекология. 2012. Т. 4/2. С. 39–46. [Shifman E.M., Roitman E.V., Krugova L.V., Vartanov V.Ya., Khutorskaya N.N. Hematological changes in HIV-infected pregnant women against the background of chemoprophylaxis with antiretroviral drugs. Obstetrics and gynecology, 2012, Vol. 4/2, рp. 39–46 (In Russ.)].
Review
For citations:
Daminov T.A., Tuychiev L.N., Khudaykulova G.K., Rakhmatullaeva Sh.B., Muminva M.T. Hematological disorders in HIV-infected children on the background of antiretroviral therapy. HIV Infection and Immunosuppressive Disorders. 2021;13(3):73-80. (In Russ.) https://doi.org/10.22328/2077-9828-2021-13-3-73-80
Views:
3271
.png)
Email this article 